Summary
This 8-K filing by Schering-Plough Corporation (note: the filing states Merck & Co. in the initial prompt but the content clearly refers to Schering-Plough) on November 19, 2003, provides two key pieces of information for investors. Firstly, the company announced its intention to raise a significant $1.75 billion through a public offering of senior notes. This move suggests potential strategic investments, debt refinancing, or general corporate purposes, and investors should monitor the terms of these notes and their impact on the company's leverage. Secondly, the filing discloses that Schering-Plough received a formal order from the SEC to investigate compliance by its Polish subsidiaries with the U.S. Foreign Corrupt Practices Act (FCPA). While the company is cooperating, such investigations can carry potential risks and liabilities, and investors will want to closely follow the developments and any potential outcomes.
Key Highlights
- 1Schering-Plough plans to raise $1.75 billion through an underwritten registered public offering of senior notes.
- 2The company is cooperating with an SEC investigation into potential Foreign Corrupt Practices Act (FCPA) violations by its Polish subsidiaries.
- 3The SEC issued a formal order of investigation regarding the FCPA compliance of the Polish subsidiaries.
- 4The company had previously received voluntary document requests from the SEC related to this inquiry.
- 5The filing includes the press release announcing the senior notes offering as an exhibit.